Top 25 Publications from FY17 Based on Impact Factor

  1. Ombrello MJ; Arthur VL; Remmers EF; Hinks A; Tachmazidou I; Grom AA; Foell D; Martini A; Gattorno M; Özen S. Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Annals of the rheumatic diseases. 2017; 76:906-913.
  2. Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative.. Annals of the rheumatic diseases. 2017; 76:782-791.
  3. Hinks A; Bowes J; Cobb J; Ainsworth HC; Marion MC; Comeau ME; Sudman M; Han B; Juvenile Arthritis Consortium for Immunochip; Becker ML. Fine-mapping the MHC locus in juvenile idiopathic arthritis (JIA) reveals genetic heterogeneity corresponding to distinct adult inflammatory arthritic diseases. Annals of the rheumatic diseases. 2017; 76:765-772.
  4. Rossetti M; Spreafico R; Consolaro A; Leong JY; Chua C; Massaf M; Saidin S; Magni-Manzoni S; Arkachaisri T; Wallace CA. TCR repertoire sequencing identifies synovial Treg cell clonotypes in the bloodstream during active inflammation in human arthritis. Annals of the rheumatic diseases. 2017; 76:435-441.
  5. Bracaglia C; de Graaf K; Pires Marafon D; Guilhot F; Ferlin W; Prencipe G; Caiello I; Davì S; Schulert G; Ravelli A. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Annals of the rheumatic diseases. 2017; 76:166-172.
  6. Spreafico R; Rossetti M; Whitaker JW; Wang W; Lovell DJ; Albani S. Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4(+) T cell activation pathways. Proceedings of the National Academy of Sciences of the United States of America. 2016; 113:13845-13850.
  7. Rider LG; Aggarwal R; Pistorio A; Bayat N; Erman B; Feldman BM; Huber AM; Cimaz R; Cuttica RJ; de Oliveira SK. 2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Juvenile Dermatomyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Arthritis and Rheumatology. 2017; 69:911-923.
  8. Schulert GS; Fall N; Harley JB; Shen N; Lovell DJ; Thornton S; Grom AA. Monocyte MicroRNA Expression in Active Systemic Juvenile Idiopathic Arthritis Implicates MicroRNA-125a-5p in Polarized Monocyte Phenotypes. Arthritis and Rheumatology. 2016; 68:2300-2313.
  9. Strait RT; Thornton S; Finkelman FD. C gamma 1 Deficiency Exacerbates Collagen-Induced Arthritis. Arthritis and Rheumatology. 2016; 68:1780-1787.
  10. Shaw MA; Gao Z; McElhinney KE; Thornton S; Flick MJ; Lane A; Degen JL; Ryu JK; Akassoglou K; Mullins ES. Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease. The Journal of neuroscience : the official journal of the Society for Neuroscience. 2017; 37:3776-3788.
  11. Yu T; Enioutina EY; Brunner HI; Vinks AA; Sherwin CM. Clinical Pharmacokinetics and Pharmacodynamics of Biologic Therapeutics for Treatment of Systemic Lupus Erythematosus. Clinical Pharmacokinetics. 2017; 56:107-125.
  12. Gmuca S; Xiao R; Brandon TG; Pagnini I; Wright TB; Beukelman T; Morgan EM; Weiss PF. Multicenter inception cohort of enthesitis-related arthritis: variation in disease characteristics and treatment approaches. Arthritis Research and Therapy. 2017; 19:84.
  13. Brachat AH; Grom AA; Wulffraat N; Brunner HI; Quartier P; Brik R; McCann L; Ozdogan H; Rutkowska-Sak L; Schneider R. Early changes in gene expression and inflammatory proteins in systemic juvenile idiopathic arthritis patients on canakinumab therapy. Arthritis Research and Therapy. 2017; 19:13.
  14. Phillippi K; Hoeltzel M; Byun Robinson A; Kim S; Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigators. Race, Income, and Disease Outcomes in Juvenile Dermatomyositis. The Journal of Pediatrics. 2017; 184:38-44.e1.
  15. Askew RL; Cook KF; Keefe FJ; Nowinski CJ; Cella D; Revicki DA; Morgan DeWitt EM; Michaud K; Trence DL; Amtmann D. A PROMIS Measure of Neuropathic Pain Quality. Value in Health. 2016; 19:623-630.
  16. Tran ST; Guite JW; Pantaleao A; Pfeiffer M; Myer GD; Sil S; Thomas SM; Ting TV; Williams SE; Edelheit B. Preliminary Outcomes of a Cross-Site Cognitive- Behavioral and Neuromuscular Integrative Training Intervention for Juvenile Fibromyalgia. Arthritis Care and Research. 2017; 69:413-420.
  17. Gulati G; Jones JT; Lee G; Altaye M; Beebe DW; Meyers-Eaton J; Wiley K; Brunner HI; DiFrancesco MW. Altered Blood-Brain Barrier Permeability in Patients With Systemic Lupus Erythematosus: A Novel Imaging Approach. Arthritis Care and Research. 2017; 69:299-305.
  18. Jones JT; Carle AC; Wootton J; Liberio B; Lee J; Schanberg LE; Ying J; Morgan DeWitt E; Brunner HI. Validation of Patient-Reported Outcomes Measurement Information System Short Forms for Use in Childhood-Onset Systemic Lupus Erythematosus. Arthritis Care and Research. 2017; 69:133-142.
  19. Yazdany J; Bansback N; Clowse M; Collier D; Law K; Liao KP; Michaud K; Morgan EM; Oates JC; Orozco C. Rheumatology Informatics System for Effectiveness: A National Informatics-Enabled Registry for Quality Improvement. Arthritis Care and Research. 2016; 68:1866-1873.
  20. Brunner HI; Bennett MR; Abulaban K; Klein-Gitelman MS; O'Neil KM; Tucker L; Ardoin SP; Rouster-Stevens KA; Onel KB; Singer NG. Development of a Novel Renal Activity Index of Lupus Nephritis in Children and Young Adults. Arthritis Care and Research. 2016; 68:1003-1011.
  21. Wenderfer SE; Ruth NM; Brunner HI. Advances in the care of children with lupus nephritis. Pediatric Research. 2017; 81:406-414.
  22. Zeft AS; Prahalad S; Schneider R; Dedeoglu F; Weiss PF; Grom AA; Mix C; Pope Rd CA. Systemic onset juvenile idiopathic arthritis and exposure to fine particulate air pollution. Clinical and Experimental Rheumatology. 2016; 34:946-952.
  23. Consolaro A; Morgan EM; Giancane G; Rosina S; Lanni S; Ravelli A. Information technology in paediatric rheumatology.. Clinical and Experimental Rheumatology. 2016; 34:S11-S16.
  24. Morgan EM; Mara CA; Huang B; Barnett K; Carle AC; Farrell JE; Cook KF. Establishing clinical meaning and defining important differences for Patient-Reported Outcomes Measurement Information System (PROMISA (R)) measures in juvenile idiopathic arthritis using standard setting with patients, parents, and providers. Quality of Life Research. 2017; 26:565-586.
  25. Lipstein EA; Lovell DJ; Denson LA; Kim SC; Spencer C; Ittenbach RF; Britto MT. High Levels of Decisional Conflict and Decision Regret When Making Decisions About Biologics. Journal of Pediatric Gastroenterology and Nutrition. 2016; 63:e176-e181.